Pharmaceutical Economics and Policy

Работ: 27

Enhancing global access to cancer medicines
Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac +13
Обзорная статьяEconomic and Financial Impacts of CancerCA A Cancer Journal for Clinicians2020Цитирований: 1
ABI
Shortages and price variability of essential cytotoxic medicines for treating children with cancers
Yehoda M. Martei, Kotoji Iwamoto, Ronald D. Barr +2
СтатьяPharmaceutical Economics and PolicyBMJ Global Health2020Цитирований: 1
ABI
563 Long-term acceptance of nebivolol in idiopathic dilated cardiomyopathy patients
Т. А. Абдуллаев, Н. А. Курбанов, I. R. Bekbulatova +1
СтатьяHeart Failure Treatment and ManagementEuropean Journal of Heart Failure Supplements2006Цитирований: 0
ABI
A Status Report on the Health Care Sector in France
N. Lalitha, Samira Guennif
СтатьяPharmaceutical Economics and PolicyJournal of Health Management2008Цитирований: 0
ABI
The Politics and Strategy of Industry Self-Regulation: The Pharmaceutical Industry's Principles for Ethical Direct-to-Consumer Advertising as a Deceptive Blocking Strategy
Denis Arnold, James L. Oakley
СтатьяPharmaceutical industry and healthcareJournal of Health Politics Policy and Law2013Цитирований: 0
ABI
P767Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment
Aleksandr B. Shek, Р. Д. Курбанов, G J Abdullaeva +3
СтатьяLipoproteins and Cardiovascular HealthEuropean Heart Journal2017Цитирований: 0
ABI
PO432 Compliance With Drug Therapy In Relation to Acute Coronary Events (A Fragment of the Register RACSMI-Uz)
G. Nagaeva, S. Nagaev
СтатьяPharmaceutical Economics and PolicyGlobal Heart2018Цитирований: 0
ABI
PO433 Compliance With Drug Therapy In Relation to Acute Coronary Events (A Fragment of the Register RACSMI-Uz)
G. Nagaeva, S. Nagaev
СтатьяPharmaceutical Economics and PolicyGlobal Heart2018Цитирований: 0
ABI
Antimicrobial Medicines Consumption in Eastern Europeand Central Asia – An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action
Jane Robertson, Kotoji Iwamoto, Iris Hoxha +18
СтатьяAntibiotic Use and ResistanceFrontiers in Pharmacology2019Цитирований: 0
ABI
PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW
S. Djalalov, Dilfuza Djalalova, Murray Krahn +2
СтатьяHealth Systems, Economic Evaluations, Quality of LifeValue in Health2019Цитирований: 0
ABI
O'zbekistonda farmasevtika sanoatining rivojlanishi
Sh. Yakubova
СтатьяPharmaceutical Economics and PolicyОбщество и инновации2021Цитирований: 0
ABI
Pharmacoeconomics and the Patients’ Compliance as an Essential part of Successful therapy of iron Deficiency Anemia.
Khodjieva Gulirano Sayfullaevna
СтатьяHealth Systems, Economic Evaluations, Quality of LifeIndonesian Journal of Innovation Studies2022Цитирований: 0
ABI
Sudden Spurt in Pediatric Patients with AKI in Uzbekistan: A Call for International Drug Quality Control and Pharmaceutical Legislation
Nodira Murtalibova, Sidharth Kumar Sethi, Rupesh Raina +2
СтатьяPharmaceutical Quality and CounterfeitingKidney3602023Цитирований: 0
ABI
AVAILABILITY AND COSTS OF MEDICINES FOR THE TREATMENT OF TUBERCULOSIS
Batirova Barchinoy Tadjimukhammadovna
СтатьяTuberculosis Research and EpidemiologyInternational Journal of Medical Sciences And Clinical Research2024Цитирований: 0
ABI
Content analysis of anticancer drugs of the pharmaceutical market of the republic of Uzbekistan
Шохиста Шарофиддин кизи Мелибоева, Мизроб Мавлонович Болтаев, Umida Narzulaeva
СтатьяPharmaceutical Economics and PolicyBIO Web of Conferences2024Цитирований: 0
ABI
Fınancıal sustaınabılıty and rısk in antı-agıng startups
Mehmet Mustafa Besirikli
СтатьяPharmaceutical Economics and PolicyJournal of Forensic Accounting Profession2024Цитирований: 0
ABI
Drug-drug interactions in clinical practice: a literature review and SWOT analysis
Valeriya O. Barysheva, О. S. Golikova, В. Г. Кудрина +1
Обзорная статьяPharmaceutical Practices and Patient OutcomesMedical Technologies Assessment and Choice2024Цитирований: 0
ABI
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
Homie Razavi, Imam Waked, Huma Qureshi +97
СтатьяHepatitis C virus researchJournal of Hepatology2025Цитирований: 0
ABI
EXPERIMENTAL ESTIMATION OF THE EFFICIENCY OF NEW POLICY IN THE PHARMACEUTICAL INDUSTRY
Sokhibmalik Khomidov
СтатьяPharmaceutical Economics and PolicyЭкономика и предпринимательство2025Цитирований: 0
ABI
The Range of Medicines in The City of Samarkand: A Marketing Analysis
Makhmudova Maftuna Mehrojovna, Rayimqulova Ch.A.
СтатьяEducational Management and QualityEuropean International Journal of Multidisciplinary Research and Management Studies2025Цитирований: 0
ABI
Blood-pressure and cholesterol lowering therapy with polypill and separate drug, their comparative effectiveness in persons with hypertension and dyslipidemia
Shakhlo Fayzullaeva, Г А Хамидуллаева
СтатьяMedication Adherence and ComplianceAtherosclerosis2025Цитирований: 0
ABI
Validation of Kazakh and Russian Generic Drug Questionnaire
Zhandulla Nakipov, U. N. Musaev, Indira Smagylova +7
СтатьяPharmaceutical Economics and PolicyMedical Journal of the Islamic Republic of Iran2025Цитирований: 0
ABI
Comparative Analysis of the Efficacy of a Polypill and a Free Combination of Antihypertensive Drugs and Statins in the Context of an Individualized Treatment Strategy
Shakhlo S. Fayzullaeva, Gulnoz A. Khamidullaeva, Guzal Zh. Abdullaeva +2
СтатьяPharmaceutical Economics and PolicyInternational Journal of Biomedicine2025Цитирований: 0
ABI
STAGES OF DEVELOPMENT OF NEW MEDICINAL PRODUCTS
A.K. SADANOV, B.B. BAIMAKHANOVA, Z.Zh. TURLYBAYEVA +2
СтатьяPharmaceutical Quality and CounterfeitingМИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ2025Цитирований: 0
ABI
Rare diseases as a global priority: the CIS Orphan Forum and the path toward collaboration with BRICS
Nuriya Z. Musina, Ahmed Al Saidi, Ayman W. El-Hattab +27
СтатьяGenomics and Rare DiseasesThe BRICS Health Journal2026Цитирований: 0
ABI